Smith Anderson advised Fortrea on the deal. Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO) that helps make life changing therapies for patients, has...
Arsenal Capital Partners’ Acquisition of Endpoint Clinical and Patient Access Businesses From Fortrea
Azurity’s Acquisition of Arbor Pharmaceuticals
Wilson Sonsini Goodrich & Rosati and Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan advised Azurity on the deal while King & Spalding represented Arbor Pharmaceuticals. Azurity...